Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EMERGING MARKETS-Rand jumps despite ratings downgrade, EM stocks rally on vaccine hopes

Mon, 23rd Nov 2020 10:18

* Markets shrug off ratings downgrade on S.Africa

* EM stocks hit new 32-month highs

* Vaccine hopes boost global mood

* Lira bucks trend with almost 2% fall

By Sruthi Shankar

Nov 23 (Reuters) - The South African rand jumped on Monday
despite a pair of sovereign ratings downgrades, while emerging
market stocks raced to a fresh 32-month high on hopes of an
early rollout of COVID-19 vaccines.

The rand gained 0.8% with the safe-haven dollar under
pressure, while a widely watched EM equities index
rose 0.9% to hit new highs since March 2018, supported by strong
gains across Asian bourses.

Investors shrugged off news that credit rating agencies
Fitch and Moody's had both cut South Africa's sovereign ratings
further into junk - moves that the finance ministry warned could
drive up the government's borrowing costs and constrain the
fiscal options.

Russia's rouble, Mexico's peso rose about half
a percent each, while their Asian peers also edged higher.

The mood across global markets brightened at the start of
the week as a top U.S. official said health regulators would
likely grant approval for distribution of the COVID-19 vaccine
produced by Pfizer and German partner BioNTech
in mid-December.

Meanwhile, Britain's AstraZeneca said its vaccine
could be around 90% effective without any serious side effects.

"In a reversal of the COVID trade, some currencies with weak
fundamentals (such as ZAR, TRY) should play catch-up to the
stronger ones (North Asian currencies for example)," EM
strategists at Societe Generale wrote in a note.

"This rotation means that the high degree of divergence seen
in 2020 will continue into next year and leave average EM
currency performance roughly flat."

Stocks and currencies in the developing world surged to 2018
highs earlier in November, boosted by trade-reliant Asian and
Mexican markets after Joe Biden's victory in the U.S.
presidential election raised hopes of friendlier trade policies.

The Turkish lira remained an outlier, giving back
more than 1% to trade at 7.74 per dollar after a stellar run in
the past weeks following a 475-basis-points policy rate hike by
the central bank.

Analysts said some of the weakness was due to profit-taking
after the currency rallied from a record low of 8.58 against the
dollar earlier this month.

For GRAPHIC on emerging market FX performance in 2020, see http://tmsnrt.rs/2egbfVh
For GRAPHIC on MSCI emerging index performance in 2020, see https://tmsnrt.rs/2OusNdX

For TOP NEWS across emerging markets

For CENTRAL EUROPE market report, see

For TURKISH market report, see

For RUSSIAN market report, see

(Reporting by Sruthi Shankar in Bengaluru, graphic by Marc
Jones in London
Editing by Gareth Jones)

More News
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.